Pipratecol
Code | Size | Price |
---|
TAR-T34073-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T34073-50mg | 50mg | £1,661.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-T34073-100mg | 100mg | £2,079.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
Pipratecol can affect platelet aggregation and the platelet release reaction.
CAS:
15534-05-1
Formula:
C19H24N2O4
Molecular Weight:
344.411
Purity:
0.98
SMILES:
COc1ccccc1N1CCN(CC(O)c2ccc(O)c(O)c2)CC1
References
Laubie M, Le Douarec JC. [Pharmacological study of pipratecol (JP 711) and of a pharmaceutical combination raubasine-JP 711]. Arzneimittelforschung. 1969 Nov;19(11):1820-6. French. PubMed PMID: 4391788.
Cattaneo M, D'Angelo A, Mannucci PM, Pareti F, Vanasia S, Vigan?. [Effect of raubasine and pipratecol on platelet aggregation and on the platelet release reaction]. Clin Ter. 1980 Feb 29;92(4):359-68. Italian. PubMed PMID: 6108818.
Beil W, Staar U, Sewing KF. Substituted thieno[3,4-d]imidazoles, a novel group of H+/K(+)-ATPase inhibitors. Differentiation of their inhibition characteristics from those of omeprazole. Eur J Pharmacol. 1990 Oct 23;187(3):455-67. PubMed PMID: 1963594.
Passero S, Battistini N. Effect of a Raubasine-Pipratecol association (Isosarpan) on the sympathetic control of cerebral circulation. Acta Neurol (Napoli). 1979 Feb;1(1):45-58. PubMed PMID: 433680.